Lisdexamfetamine Dimesylate Tablet, Chewable shortage
Current 18 presentations · 3 manufacturers · first FDA posting 2023-07-14 · last update 2026-10-15
Manufacturers: Novadoz Pharmaceuticals LLC, Sun Pharmaceutical Industries, Inc., Takeda Pharmaceuticals USA Inc.
Stated reasons (per FDA): Not stated
Presentations
| Presentation | Manufacturer | Status | Reason | Notes (FDA) | Dates |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 72205-132-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 72205-133-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 72205-134-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 72205-135-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 72205-136-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 72205-137-91) | Novadoz Pharmaceuticals LLC | Current Available |
— | Posted 07/14/2023 Updated 09/16/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 10 mg (NDC 57664-083-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 20 mg (NDC 57664-084-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 30 mg (NDC 57664-085-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 40 mg (NDC 57664-086-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 50 mg (NDC 57664-087-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Lisdexamfetamine Dimesylate, Tablet, Chewable, 60 mg (NDC 57664-088-88) | Sun Pharmaceutical Industries, Inc. | Current Available |
— | Posted 07/14/2023 Updated 09/18/2026 | |
| Vyvanse, Tablet, Chewable, 10 mg (NDC 59417-115-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Tablet, Chewable, 20 mg (NDC 59417-116-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Tablet, Chewable, 30 mg (NDC 59417-117-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Tablet, Chewable, 40 mg (NDC 59417-118-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Tablet, Chewable, 50 mg (NDC 59417-119-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 | |
| Vyvanse, Tablet, Chewable, 60 mg (NDC 59417-120-01) | Takeda Pharmaceuticals USA Inc. | Current Available |
— | Posted 07/14/2023 Updated 10/15/2026 |
Get the weekly shortage roundup: a free email of FDA shortage changes (open form)